"I want to share my story and help others like myself living with MPN. MPN Research Foundation has been that source of community support for my family and I as we learn to deal with living with a disease on a daily basis."

Incyte meets goals in Myelofibrosis trial

December 2010

Incyte Corp. has reported that they have met their goals in their trial of INCB18424 in Myelofibrosis patients. This drug, which treats symptoms of the blood cancer, would be the first drug on the market for a myeloproliferative disorder. In August Incyte indicated that they would also test this drug in Polycythemia Vera patients.

Click here to read the full article

 

Your donation goes a long way.

Learn more about how you can help support the MPN Research Foundation and the impact your contributions can make.

Donate Now
 
 
 

Subscribe

Want to learn more about the MPN Research Foundation? Sign up for our Newsletter and Research Alerts!

Newsletter Signup

 
 

Connect with Us

MPN Research Foundation wants to hear from you. Connect with us through our social networks or send us an email.

Email Facebook Twitter LinkedIn